Skip to Content

Cinqair Side Effects

Generic Name: reslizumab

Note: This page contains information about the side effects of reslizumab. Some of the dosage forms included on this document may not apply to the brand name Cinqair.

For the Consumer

Applies to reslizumab: intravenous solution

In addition to its needed effects, some unwanted effects may be caused by reslizumab (the active ingredient contained in Cinqair). In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking reslizumab, check with your doctor or nurse immediately:

Rare
  • Cough
  • difficulty with swallowing
  • dizziness
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fast heartbeat
  • hives, itching, or skin rash
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • redness of the skin
  • tightness in the chest
  • unusual tiredness or weakness

Minor Side Effects

Some of the side effects that can occur with reslizumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common:
  • Throat pain
Incidence not known:
  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

For Healthcare Professionals

Applies to reslizumab: intravenous solution

Gastrointestinal

Common (1% to 10%): Oropharyngeal pain[Ref]

Hematologic

Very common (10% or more): Elevated baseline creatine phosphokinase (CPK) (14%)[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Anaphylaxis[Ref]

Immunologic

Common (1% to 10%): Treatment emergent anti-reslizumab (the active ingredient contained in Cinqair) antibody response (low titer and often transient)[Ref]

Musculoskeletal

Very common (10% or more): Elevated baseline creatine phosphokinase (CPK) (14%)
Common (1% to 10%): Myalgia, chest pain, neck pain, muscle spasms, extremity pain, muscle fatigue, musculoskeletal pain[Ref]

Oncologic

Frequency not reported: Malignancy[Ref]

References

1. "Product Information. Cinqair (reslizumab)." Teva Pharmaceuticals USA, North Wales, PA.

Not all side effects for Cinqair may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide